Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a)

Digvijay Singh, John Mallon, Anustup Poddar, Yanbo Wang, Ramreddy Tippana, Olivia Yang, Scott Bailey, Taekjip Ha

Proceedings of the National Academy of Sciences · 2018 · 215 citations · 38 references

DOIFull text

Open access

Concepts

TL;DR

Microbial CRISPR systems, originally adaptive immunity against foreign DNA, have been repurposed for genome engineering, with CRISPR‑Cas9 being the most widely used. The study seeks novel CRISPR enzymes to overcome limitations of Cas9. The authors employed single‑molecule fluorescence and biochemical assays to characterize Cpf1’s DNA interrogation, cleavage, and product‑release kinetics and specificity. The work identified CRISPR‑Cpf1 systems and revealed key differences from Cas9 that expand CRISPR applications beyond Cas9’s scope.

Abstract

Significance Adaptive immunity against foreign DNA elements in microbes, conferred by their CRISPR systems, has been repurposed for wide-ranging genome-engineering applications. The CRISPR-Cas9 system has been the most widely used system. But to overcome some of its major limitations, the search for novel CRISPR enzymes has been a significant area of interest. One such search led to the discovery of CRISPR-Cpf1 systems. We used single-molecule fluorescence analysis and biochemical assays to characterize the kinetics, specificity, and mechanism of Cpf1’s DNA interrogation, cleavage, and cleavage-product release. Some major differences from Cas9 were observed which will help the use of Cpf1 in areas outside the realm of Cas9 and effectively broaden the scope of CRISPR-based applications.

References

38